About four of every five patients with COVID-19-related olfactory loss report smell recovery within six months.
Long-term marine omega-3 supplementation is associated with an increased risk for atrial fibrillation (AF).
There was an increase in depression and anxiety scores among U.S. adults from August to December 2020, followed by a decrease.
Differences in sleep patterns, which can be objectively measured with wrist-worn accelerometers, are the norm among patients with lifetime psychiatric conditions.
Infectious mononucleosis during childhood, particularly during adolescence, appears to be a risk factor for subsequent diagnosis of MS.
There appears to be a dose-dependent risk for incident cardiovascular disease associated with enzyme-inducing antiseizure medications.
An additional 53.2 million cases of major depressive disorder and 76.2 million cases of anxiety disorders globally were estimated due to the COVID-19 pandemic.
Depression during pregnancy is associated with increased odds of preterm birth and low birth weight, with stronger associations seen for African Americans.
Osmophobia is prevalent among patients with different migraine subtypes, and it also occurs in some patients with tension-type headaches.